European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption | SpringerLink
MABEL Fund
Liese Barbier - Postdoctoral Researcher - KU Leuven | LinkedIn
Liese Barbier - Postdoctoral Researcher - KU Leuven | LinkedIn
Salon Liese
Loop | Liese Barbier
Effectively Educating Clinicians And Patients On Biosimilars Across Europe Getting The Right Message Across
News & events - The MABEL FUND - Market Analysis of Biologics and Biosimilars following Loss of Exclusivity
Liese Barbier (@LieseBarbier) / Twitter
KU Leuven who's who - Liese Barbier
Biosimilar medicines in Belgium– Perspective from rheumatology
DONALD SINGER: HEALTH, ART AND SCIENCE: European cooperation on healthcare discussed at FPM-HPT conference at Erasmus University in Rotterdam
Médicaments biosimilaires en Belgique Perspective de la rhumatologie
Percepties over biosimilar geneesmiddelen bij Belgische patiënten in de ambulante zorg
Donald Singer on Twitter: "Liese Barbier discussing biosimilars at European Cooperation in Healthcare conference @ESHPM_EUR @FPGMed https://t.co/lPNMEtc099 https://t.co/TRfHS2rrey" / Twitter
PDF) The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review
RePub, Erasmus University Repository: The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars
Effectively Educating Clinicians and Patients on Biosimilars
Liese Barbier on LinkedIn: Regulatory Information and Guidance on Biosimilars and Their Use Across…
Liese Barbier, apotheker-onderzoeker, KU Leuven, België on Vimeo
DONALD SINGER: HEALTH, ART AND SCIENCE: European cooperation on healthcare discussed at FPM-HPT conference at Erasmus University in Rotterdam
Loop | Liese Barbier
Liese Barbier (@LieseBarbier) / Twitter
Biosimilars Tendering in Europe: Key Learnings Towards Sustainable Practices
Liese Barbier - Biosimilars Nederland
